What Is 1p36 Deletion Syndrome

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 1p36 deletion syndrome is a rare genetic disorder caused by the loss of genetic material from the short arm of chromosome 1, affecting approximately 1 in 5,000 to 1 in 10,000 live births. Symptoms include developmental delays, intellectual disability, seizures, and distinct facial features.

Key Facts

1p36 deletion syndrome affects an estimated 1 in 5,000 to 1 in 10,000 newborns.
It is the most common terminal deletion syndrome involving chromosome 1.
About 80% of cases occur de novo, meaning they are not inherited.
Seizures affect up to 70% of individuals with the syndrome.
The condition was first described in medical literature in 1997 by researchers at the University of Tokyo.

Overview

1p36 deletion syndrome is a chromosomal disorder resulting from the deletion of a segment on the short arm (p arm) of chromosome 1. This missing genetic material disrupts normal development, leading to a wide range of physical, neurological, and cognitive challenges. The severity of symptoms varies widely among affected individuals, depending on the size and location of the deletion.

First recognized in the late 1990s, the syndrome is now better understood due to advances in genetic testing, such as chromosomal microarray analysis. Early diagnosis is critical for managing symptoms and improving quality of life. While there is no cure, multidisciplinary care can address many of the associated health issues.

Chromosome 1: The deletion occurs on the p arm of chromosome 1, specifically at band 36, giving the syndrome its name 1p36.
Incidence rate: It affects approximately 1 in 5,000 to 1 in 10,000 live births, making it one of the most common microdeletion syndromes.
De novo mutations: About 80% of cases are not inherited and occur spontaneously during early embryonic development.
Facial features: Common traits include a large forehead, deep-set eyes, a flat nasal bridge, and a pointed chin.
Developmental delays: Most children experience significant delays in motor skills, speech, and cognitive development by age two.

How It Works

Understanding 1p36 deletion syndrome requires examining how missing genes affect cellular functions and development. The deletion removes multiple genes critical for brain development, heart formation, and sensory processing. Below are key terms and concepts that explain the biological mechanisms involved.

Deletion size: The deleted segment ranges from 1.5 to 9.5 million base pairs, with larger deletions often linked to more severe symptoms.
Genes involved: Key genes such as SKI, MMP23B, and PRDM16 are often lost, impacting neural and cardiac development.
Chromosomal microarray: This test detects the deletion with over 95% accuracy and is the gold standard for diagnosis.
Seizures: Up to 70% of individuals develop epilepsy, often beginning in infancy and requiring long-term medication.
Cardiac defects: Around 40% of patients have congenital heart issues, including septal defects and patent ductus arteriosus.
Hearing and vision: Sensorineural hearing loss affects 60% of cases, while vision problems such as cortical visual impairment are also common.

Comparison at a Glance

Comparing 1p36 deletion syndrome to other genetic disorders helps clarify its unique profile and diagnostic challenges.

Disorder	Chromosome Involved	Incidence	Common Symptoms	Inheritance Pattern
1p36 Deletion Syndrome	Chromosome 1	1 in 5,000–10,000	Developmental delay, seizures, facial dysmorphism	Mostly de novo
Down Syndrome	Chromosome 21	1 in 700	Intellectual disability, heart defects, flat facial profile	Trisomy 21 (usually de novo)
Prader-Willi Syndrome	Chromosome 15	1 in 10,000–30,000	Obesity, hypotonia, hyperphagia	Imprinting defect or deletion
Wolf-Hirschhorn Syndrome	Chromosome 4	1 in 50,000	Severe intellectual disability, seizures, 'Greek helmet' facial appearance	De novo or inherited
Williams Syndrome	Chromosome 7	1 in 7,500–20,000	Cardiovascular disease, elfin faces, hypersociability	Deletion, usually de novo

This comparison highlights that while 1p36 deletion syndrome is rarer than Down syndrome, it shares features like developmental delay and congenital anomalies. However, its distinct genetic origin and pattern of deletion make it a unique diagnostic entity requiring specialized testing and care pathways.

Why It Matters

Recognizing 1p36 deletion syndrome has significant implications for families, healthcare providers, and genetic counselors. Early diagnosis enables timely interventions that can improve developmental outcomes and reduce complications.

Early intervention: Physical, occupational, and speech therapy starting in infancy can improve motor and communication skills.
Family planning: Genetic counseling helps parents understand recurrence risks, which are less than 1% for de novo cases.
School support: Individualized education plans (IEPs) are often necessary due to intellectual and learning disabilities.
Medical monitoring: Regular cardiac, hearing, and neurological evaluations are essential for managing comorbidities.
Research advancements: Ongoing studies aim to link specific genes in the deleted region to symptoms, improving targeted therapies.
Global awareness: Advocacy groups like the 1p36 Deletion Foundation raise awareness and support research funding.

As genetic testing becomes more accessible, more cases are being identified earlier, leading to better outcomes. Continued research and public education are vital to improving the lives of those affected by this complex condition.